Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 222

1.

The potential impact of expanding antiretroviral therapy and combination prevention in Vietnam: towards elimination of HIV transmission.

Kato M, Granich R, Bui DD, Tran HV, Nadol P, Jacka D, Sabin K, Suthar AB, Mesquita F, Lo YR, Williams B.

J Acquir Immune Defic Syndr. 2013 Aug 15;63(5):e142-9. doi: 10.1097/QAI.0b013e31829b535b.

2.

Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model.

Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG.

Lancet. 2009 Jan 3;373(9657):48-57. doi: 10.1016/S0140-6736(08)61697-9. Epub 2008 Nov 27.

PMID:
19038438
3.

Enhancing the benefits of antiretroviral therapy in Vietnam: towards ending AIDS.

Kato M, Long NH, Duong BD, Nhan do T, Nguyen TT, Hai NH, Giang le M, Hoa do M, Van NT, Suthar AB, Fontaine C, Nadol P, Lo YR, McConnell MS.

Curr HIV/AIDS Rep. 2014 Dec;11(4):487-95. doi: 10.1007/s11904-014-0235-7. Review.

4.

Home testing and counselling to reduce HIV incidence in a generalised epidemic setting: a mathematical modelling analysis.

Ying R, Sharma M, Celum C, Baeten JM, van Rooyen H, Hughes JP, Garnett G, Barnabas RV.

Lancet HIV. 2016 Jun;3(6):e275-82. doi: 10.1016/S2352-3018(16)30009-1. Epub 2016 May 11.

5.

Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: a modeling analysis for Ukraine.

Alistar SS, Owens DK, Brandeau ML.

PLoS Med. 2011 Mar;8(3):e1000423. doi: 10.1371/journal.pmed.1000423. Epub 2011 Mar 1.

6.

What is the cost of providing outpatient HIV counseling and testing and antiretroviral therapy services in selected public health facilities in Nigeria?

Aliyu HB, Chuku NN, Kola-Jebutu A, Abubakar Z, Torpey K, Chabikuli ON.

J Acquir Immune Defic Syndr. 2012 Oct 1;61(2):221-5.

PMID:
22820805
7.

The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States.

Long EF, Brandeau ML, Owens DK.

Ann Intern Med. 2010 Dec 21;153(12):778-89. doi: 10.7326/0003-4819-153-12-201012210-00004.

8.

Dropout and re-enrollment: implications for epidemiological projections of treatment programs.

Klein DJ, Bershteyn A, Eckhoff PA.

AIDS. 2014 Jan;28 Suppl 1:S47-59. doi: 10.1097/QAD.0000000000000081.

PMID:
24468946
9.

The potential impact of expanding antiretroviral therapy and combination prevention in Vietnam: the modeling approach.

Suthar AB, Bui DD, Granich RM, Nadol P, Tran HV, Sabin K, Williams BG, Lo YR, Kato M.

J Acquir Immune Defic Syndr. 2014 Jun 1;66(2):e62-3. doi: 10.1097/QAI.0000000000000139. No abstract available.

PMID:
24828271
10.

Modelling the impact and cost-effectiveness of combination prevention amongst HIV serodiscordant couples in Nigeria.

Mitchell KM, L├ępine A, Terris-Prestholt F, Torpey K, Khamofu H, Folayan MO, Musa J, Anenih J, Sagay AS, Alhassan E, Idoko J, Vickerman P.

AIDS. 2015 Sep 24;29(15):2035-44. doi: 10.1097/QAD.0000000000000798.

11.

Cost-effectiveness of integrating methadone maintenance and antiretroviral treatment for HIV-positive drug users in Vietnam's injection-driven HIV epidemics.

Tran BX, Ohinmaa A, Duong AT, Nguyen LT, Vu PX, Mills S, Houston S, Jacobs P.

Drug Alcohol Depend. 2012 Oct 1;125(3):260-6. doi: 10.1016/j.drugalcdep.2012.02.021. Epub 2012 Mar 20.

PMID:
22436971
12.

Prevalence and correlates of alcohol use disorders during antiretroviral treatment in injection-driven HIV epidemics in Vietnam.

Tran BX, Nguyen N, Ohinmaa A, Duong AT, Nguyen LT, Van Hoang M, Vu PX, Veugelers PJ.

Drug Alcohol Depend. 2013 Jan 1;127(1-3):39-44. doi: 10.1016/j.drugalcdep.2012.06.009. Epub 2012 Jun 29.

PMID:
22749565
13.

Predicting trends in HIV-1 sexual transmission in sub-Saharan Africa through the Drug Resource Enhancement Against AIDS and Malnutrition model: antiretrovirals for 5 reduction of population infectivity, incidence and prevalence at the district level.

Palombi L, Bernava GM, Nucita A, Giglio P, Liotta G, Nielsen-Saines K, Orlando S, Mancinelli S, Buonomo E, Scarcella P, Altan AM, Guidotti G, Ceffa S, Haswell J, Zimba I, Magid NA, Marazzi MC.

Clin Infect Dis. 2012 Jul;55(2):268-75. doi: 10.1093/cid/cis380. Epub 2012 Apr 5.

PMID:
22491503
14.

Exploring the population-level impact of antiretroviral treatment: the influence of baseline intervention context.

Mishra S, Mountain E, Pickles M, Vickerman P, Shastri S, Gilks C, Dhingra NK, Washington R, Becker ML, Blanchard JF, Alary M, Boily MC; Strategic Epi-ART in India Modelling Team.

AIDS. 2014 Jan;28 Suppl 1:S61-72. doi: 10.1097/QAD.0000000000000109.

PMID:
24468948
15.

The potential impact of pre-exposure prophylaxis for HIV prevention among men who have sex with men and transwomen in Lima, Peru: a mathematical modelling study.

Gomez GB, Borquez A, Caceres CF, Segura ER, Grant RM, Garnett GP, Hallett TB.

PLoS Med. 2012;9(10):e1001323. doi: 10.1371/journal.pmed.1001323. Epub 2012 Oct 9.

16.

Potential impact of existing interventions and of antiretroviral use in female sex workers on transmission of HIV in Burkina Faso: a modeling study.

Low A, Nagot N, Konate I, Meda N, Segondy M, Van de Perre P, Mayaud P, Vickerman P.

J Acquir Immune Defic Syndr. 2015 Mar 1;68 Suppl 2:S180-8. doi: 10.1097/QAI.0000000000000441.

PMID:
25723983
18.

The epidemiological impact and cost-effectiveness of HIV testing, antiretroviral treatment and harm reduction programs.

Li J, Gilmour S, Zhang H, Koyanagi A, Shibuya K.

AIDS. 2012 Oct 23;26(16):2069-78. doi: 10.1097/QAD.0b013e3283574e54.

PMID:
22781221
19.

Key harm reduction interventions and their impact on the reduction of risky behavior and HIV incidence among people who inject drugs in low-income and middle-income countries.

Dutta A, Wirtz AL, Baral S, Beyrer C, Cleghorn FR.

Curr Opin HIV AIDS. 2012 Jul;7(4):362-8. doi: 10.1097/COH.0b013e328354a0b5. Review.

PMID:
22647588
20.

Does antiretroviral therapy prevent HIV transmission to sexual partners?

Lalani T, Hicks C.

Curr HIV/AIDS Rep. 2007 May;4(2):80-5. Review.

PMID:
17547829

Supplemental Content

Support Center